CI Trading Analysis - 10/30/2026 12:56 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

• Cigna (CI) recently reaffirmed full-year adjusted EPS guidance amid stable medical membership trends, easing prior cost-pressure concerns.
• Health insurer sector rumors of increased Medicare Advantage regulatory scrutiny surfaced earlier this month, potentially impacting managed-care names including CI.
• CI declared a quarterly dividend with ex-dividend date of December 3, 2026 (per embedded fundamentals), a near-term shareholder catalyst.
• Broad managed-care peers have seen defensive rotation due to low beta profiles; CI beta of 0.13 supports this relative stability.
• No major earnings date confirmed in provided data, but fiscal year end was 2025-12-01 per fundamentals, with next reporting likely in early 2027.

Context: Headlines suggest a stable but politically sensitive backdrop. This aligns with the embedded data showing low volatility (ATR 7.57, HV 25.97%) and bullish options flow despite a recent pullback from 52-week high.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data for CI:

• Trailing P/E is 12.30 with trailing EPS of 24.31; valuation appears low versus typical managed-care peers (often 15-20 P/E).
• PEG ratio, profit margins, revenue growth, ROE, and debt/equity are null in data — cannot be assessed.
• Market cap 79.10B, shares outstanding 264.24M, institutional ownership 63.51%.
• Dividend yield 2.09%, rate 6.24, ex-dividend 2026-12-03; fiscal year end 2025-12-01.
• Beta 0.13 (very low systematic risk); 52-week range 239.51 to 316.27.
• Forward P/E, target price, and analyst consensus are null — no street view provided.
• Fundamentals (low P/E, low beta, dividend) support a defensive bias that aligns with bullish options sentiment but diverge from recent downward daily price action (close 297.11 vs SMA 5 of 300.40).

Current Market Position

Current price per indicators: 297.11 (2026-10-29 close). Minute bars show 2026-10-30 12:25 last price 299.53, up from 298.27 at 12:20, indicating mild intraday recovery. First 2026-10-29 minute bar open 300.84, low 298.78; daily 10-29 high 300.90, low 295.44.

Intraday momentum: Last 5 minute bars show sequential highs 298.44 -> 298.37 -> 298.68 -> 299.27 -> 299.53 with rising volume (4,846 to 10,232), suggesting short-term buying interest.

Technical Analysis

Price 297.11 is below SMA 5 (300.40) but above SMA 20 (292.04) and SMA 50 (283.37); bullish alignment (50 < 20 < price < 5) with short-term cooling. RSI 61.03 shows moderate bullish momentum, not overbought. MACD line 6.24 > signal 4.99, histogram 1.25 positive — bullish momentum intact. Bollinger: price within bands (upper 317.56, lower 266.52), no squeeze signal. 30-day range high 316.26, low 262.85; current price near 56% of range. ATR 7.57 implies daily movement capacity ~2.5%.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment: Bullish

Call dollar volume: 211,110.00 (70.20%) Put dollar volume: 89,720.00 (29.80%) Total: 300,830.00

120 call contracts vs 71 put; 20 call trades vs 7 put trades. Pure directional conviction skews bullish near-term. No divergence from technical bullish bias; slight contrast to daily close below SMA 5, but minute bars confirm intraday bid.

Key Price Levels (Observational Only)